Lunai Bioworks Inc. (RENB)
$1.27-2.31%Close
SELLCRISIS · day 19
Key stats
- Market cap
- $29M
- Beta
- 0.53
- P/E (TTM)
- -1.34
- 1W
- -21.60%
- 1M
- -50.00%
- vs SPY 1W
- -21.47%
- vs SPY 1M
- -52.51%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on RENB?
- LOPJLB’s latest quantitative signal on Lunai Bioworks Inc. (RENB) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is RENB in?
- Lunai Bioworks Inc. (RENB) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Lunai Bioworks Inc. (RENB) do?
- Lunai Bioworks, Inc. functions as a pre-clinical stage biotechnology enterprise, concentrating its efforts on pioneering genetically modified cell and immunotherapeutic platforms. These advanced technologies are aimed at providing treatments for a range of infectious diseases and oncological conditions. The company's development pipeline features several candidates, specifically ENOB-HV-01, ENO…